{
    "type": "bundle",
    "id": "bundle--b225f9a7-00c3-41b4-959c-d7ab68a79cc9",
    "spec_version": "2.0",
    "objects": [
        {
            "object_marking_refs": [
                "marking-definition--fa42a846-8d90-4e51-bc29-71d5b4802168"
            ],
            "type": "malware",
            "name": "SoreFang",
            "x_mitre_aliases": [
                "SoreFang"
            ],
            "x_mitre_version": "1.0",
            "modified": "2020-10-06T16:10:42.422Z",
            "created": "2020-09-29T19:33:35.122Z",
            "x_mitre_platforms": [
                "Windows"
            ],
            "id": "malware--e33e4603-afab-402d-b2a1-248d435b5fe0",
            "description": "[SoreFang](https://attack.mitre.org/software/S0516) is first stage downloader used by [APT29](https://attack.mitre.org/groups/G0016) for exfiltration and to load other malware.(Citation: NCSC APT29 July 2020)(Citation: CISA SoreFang July 2016)",
            "labels": [
                "malware"
            ],
            "created_by_ref": "identity--c78cb6e5-0c4b-4611-8297-d1b8b55e40b5",
            "external_references": [
                {
                    "url": "https://attack.mitre.org/software/S0516",
                    "external_id": "S0516",
                    "source_name": "mitre-attack"
                },
                {
                    "url": "https://www.ncsc.gov.uk/files/Advisory-APT29-targets-COVID-19-vaccine-development-V1-1.pdf",
                    "description": "National Cyber Security Centre. (2020, July 16). Advisory: APT29 targets COVID-19 vaccine development. Retrieved September 29, 2020.",
                    "source_name": "NCSC APT29 July 2020"
                },
                {
                    "url": "https://us-cert.cisa.gov/ncas/analysis-reports/ar20-198a",
                    "description": "CISA. (2020, July 16). MAR-10296782-1.v1 \u2013 SOREFANG. Retrieved September 29, 2020.",
                    "source_name": "CISA SoreFang July 2016"
                }
            ]
        }
    ]
}